clinical trial · NCT06425900
A Study to Assess Sebaceous Gland Changes and Constituents of Sebum (Skin Oil) Induced by Clascoterone 1% Cream in Acne Patients
Acne VulgarisWinlevi (Clascoterone) cream 1%
brief summary
to compare facial sebaceous gland morphology after 3 months of clascoterone cream 1% treatment and to compare facial sebum constituents at baseline to facial sebum constituents after 3 months of clascoterone cream 1% treatment
started
Jul 1, 2024
primary completion
Mar 1, 2026
completion
Mar 1, 2026
last updated
Jan 21, 2026
official title
Histologic and Liquid Chromatography Mass Spectrometry (LCMS) Evaluation of the Sebaceous Gland Changes Induced by Clascoterone Cream 1%
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol